The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
Torrente-López, A.; Hermosilla, J.; Navas, N.; Cuadros-Rodríguez, L.; Cabeza, J.; Salmerón-García, A. The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines 2021, 9, 557. https://doi.org/10.3390/vaccines9060557
Torrente-López A, Hermosilla J, Navas N, Cuadros-Rodríguez L, Cabeza J, Salmerón-García A. The Relevance of Monoclonal Antibodies in the Treatment of COVID-19. Vaccines. 2021; 9(6):557. https://doi.org/10.3390/vaccines9060557
Chicago/Turabian StyleTorrente-López, Anabel, Jesús Hermosilla, Natalia Navas, Luis Cuadros-Rodríguez, José Cabeza, and Antonio Salmerón-García. 2021. "The Relevance of Monoclonal Antibodies in the Treatment of COVID-19" Vaccines 9, no. 6: 557. https://doi.org/10.3390/vaccines9060557